EP3329002
Transþýretín (TTR) iRNA samsetningar og aðferðir til notkunar á þeim við meðhöndlun eða fyrirbyggingu á TTR-tengdum sjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.7.2016EP published:
7.10.2020EP application number:
16750567.6
EP translation filed:
4.1.2021Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
27.7.2036Expiry date:
27.7.2026Next due date:
31.7.2026
Title:
TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
Timeline
Today
28.7.2016EP application
7.10.2020EP Publication
4.1.2021Translation submitted
15.1.2021Registration published
27.7.2026Expires
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, 3rd Floor, Cambridge, MA 02142, US
Inventor
Name:
ZIMMERMANN, TracyAddress:
Cambridge, MA 02142, US
Name:
CHAN, AmyAddress:
Cambridge, MA 02142, US
Name:
JADHAV, VasantAddress:
Cambridge, MA 02142, US
Name:
MAIER, MartinAddress:
Cambridge, MA 02142, US
Name:
RAJEEV, Kallanthottathil, G.Address:
Cambridge, MA 02142, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562199563 PDate:
31.7.2015Country:
US
Number:
201662287518 PDate:
27.1.2016Country:
US
Supplementary protection
SPC number:
SPC421
Classification
Categories:
C12N 15/113
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 1.7.2021
Expires: 27.7.2022
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 1.7.2022
Expires: 27.7.2023
Payer: Patice ehf.
Number: 8
Paid: 11.7.2023
Expires: 27.7.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 3.7.2024
Expires: 27.7.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.7.2025
Expires: 27.7.2026
Payer: Árnason Faktor ehf.